test

Onusa Chantanapongwanij

@Artia Global Partners Lp

Latest period2024 - Q3ReportedManaged Assets$366.884MTotal holdings44
Assets growth rate-29.08%Assets growth rate (2-Q avg)-12.54%Continuous growth in asset value0 quarters

Portfolio positions

This chart displays the top 10 holdings in Artia Global Partners Lp's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 44 positions.

Assets under management

The assets under management (AUM) of Artia Global Partners Lp over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 366.884M in assets, with a quarterly growth rate of -29.08% and a 2-quarter average growth rate of -12.54%. The portfolio is managed by Onusa Chantanapongwanij, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
LLYEli Lilly & Co
Recent Activity
Increased 16.2%
25.99%
$95.321M
107,593 shares@ $885.94 avg price
NVONovo-nordisk A S
Recent Activity
Increased 7.23%
24.08%
$88.319M
741,743 shares@ $119.07 avg price
VKTXViking Therapeutics Inc
Recent Activity
Increased 17.64%
9.2%
$33.737M
532,879 shares@ $63.31 avg price
ITCIIntra-cellular Therapies Inc
Recent Activity
4.32%
$15.843M
216,519 shares@ $73.17 avg price
AZNAstrazeneca Plc
Recent Activity
4.06%
$14.861M
190,752 shares@ $77.91 avg price
SLNOSoleno Therapeutics Inc
Recent Activity
Increased 190.63%
3.78%
$13.856M
274,424 shares@ $50.5 avg price
ALNYAlnylam Pharmaceuticals Inc
Recent Activity
2.63%
$9.626M
35,000 shares@ $275.03 avg price
VRTXVertex Pharmaceuticals Inc
Recent Activity
2.4%
$8.79M
18,900 shares@ $465.08 avg price
PCVXVaxcyte Inc
Recent Activity
2.38%
$8.714M
76,255 shares@ $114.28 avg price
ARGXArgenx Se
Recent Activity
2.24%
$8.206M
15,138 shares@ $542.08 avg price